Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Delia Johnson

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Plos One|September 24, 2013
Brachial artery constriction during brachial artery reactivity testing predicts major adverse clinical outcomes in women with suspected myocardial ischemia: results from the NHLBI-sponsored women's ischemia Syndrome Evaluation (WISE) StudyTara L Sedlak, B Delia Johnson, Carl J Pepine, et al.
Fertility and Sterility|April 8, 2006
Past oral contraceptive use and angiographic coronary artery disease in postmenopausal women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome EvaluationC Noel Bairey Merz, B Delia Johnson, Sarah Berga, et al.
Journal of Hypertension|April 26, 2013
Increased wave reflection and ejection duration in women with chest pain and nonobstructive coronary artery disease: ancillary study from the Women's Ischemia Syndrome EvaluationWilmer W Nichols, Scott J Denardo, B Delia Johnson, et al.
Journal of Women'S Health (2002)|January 4, 2007
Comparison of SWAN and WISE menopausal status classification algorithmsJanet M Johnston, Alicia Colvin, B Delia Johnson, et al.
American Heart Journal|March 3, 2009
The triglyceride/high-density lipoprotein cholesterol ratio predicts all-cause mortality in women with suspected myocardial ischemia: a report from the Women's Ischemia Syndrome Evaluation (WISE)Vera Bittner, B Delia Johnson, Issam Zineh, et al.
Menopause (New York, N.Y.)|October 7, 2006
The relationship between physical activity and lipoprotein subclasses in postmenopausal women: the influence of hormone therapyKelley K Pettee, Andrea M Kriska, B Delia Johnson, et al.
American Heart Journal|July 3, 2013
Adverse outcomes among women presenting with signs and symptoms of ischemia and no obstructive coronary artery disease: findings from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) angiographic core laboratoryBarry Sharaf, Todd Wood, Leslee Shaw, et al.
Contemporary Clinical Trials|November 23, 2006
The clinical trial of Women On the Move through Activity and Nutrition (WOMAN) studyLewis H Kuller, Andrea M Kriska, Laura S Kinzel, et al.
Medical Hypotheses|November 19, 2017
Premature atherosclerosis in premenopausal women: Does cytokine balance play a role?Jo-Ann Eastwood, Doris A Taylor, B Delia Johnson, et al.
Menopause (New York, N.Y.)|August 27, 2015
Carotid artery distensibility and hormone therapy and menopause: the Los Angeles Atherosclerosis StudyChrisandra Shufelt, Omeed Elboudwarej, B Delia Johnson, et al.
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Plos One|September 24, 2013
Brachial artery constriction during brachial artery reactivity testing predicts major adverse clinical outcomes in women with suspected myocardial ischemia: results from the NHLBI-sponsored women's ischemia Syndrome Evaluation (WISE) StudyTara L Sedlak, B Delia Johnson, Carl J Pepine, et al.
Fertility and Sterility|April 8, 2006
Past oral contraceptive use and angiographic coronary artery disease in postmenopausal women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome EvaluationC Noel Bairey Merz, B Delia Johnson, Sarah Berga, et al.
Journal of Hypertension|April 26, 2013
Increased wave reflection and ejection duration in women with chest pain and nonobstructive coronary artery disease: ancillary study from the Women's Ischemia Syndrome EvaluationWilmer W Nichols, Scott J Denardo, B Delia Johnson, et al.
Journal of Women'S Health (2002)|January 4, 2007
Comparison of SWAN and WISE menopausal status classification algorithmsJanet M Johnston, Alicia Colvin, B Delia Johnson, et al.
American Heart Journal|March 3, 2009
The triglyceride/high-density lipoprotein cholesterol ratio predicts all-cause mortality in women with suspected myocardial ischemia: a report from the Women's Ischemia Syndrome Evaluation (WISE)Vera Bittner, B Delia Johnson, Issam Zineh, et al.
Menopause (New York, N.Y.)|October 7, 2006
The relationship between physical activity and lipoprotein subclasses in postmenopausal women: the influence of hormone therapyKelley K Pettee, Andrea M Kriska, B Delia Johnson, et al.
American Heart Journal|July 3, 2013
Adverse outcomes among women presenting with signs and symptoms of ischemia and no obstructive coronary artery disease: findings from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) angiographic core laboratoryBarry Sharaf, Todd Wood, Leslee Shaw, et al.
Contemporary Clinical Trials|November 23, 2006
The clinical trial of Women On the Move through Activity and Nutrition (WOMAN) studyLewis H Kuller, Andrea M Kriska, Laura S Kinzel, et al.
Medical Hypotheses|November 19, 2017
Premature atherosclerosis in premenopausal women: Does cytokine balance play a role?Jo-Ann Eastwood, Doris A Taylor, B Delia Johnson, et al.
Menopause (New York, N.Y.)|August 27, 2015
Carotid artery distensibility and hormone therapy and menopause: the Los Angeles Atherosclerosis StudyChrisandra Shufelt, Omeed Elboudwarej, B Delia Johnson, et al.
Pageof 9